Goku is responsible for some of Dragon Ball's greatest battles, but not all of his fights are worthwhile winners.

The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases. "Bats ...

Viruses don't technically eat, but they do consume. Depending on what kind of virus it is, a virion will hijack a specific type of host cell and then ... as infection-fighting weapons for nearly ...

potentially offering new strategies to boost the number of immune cells that excel at fighting cancer in patients,” said Professor Ricky Johnstone, Executive Director of Cancer Research at Peter ...

UCSF scientists are taking the first steps toward creating a new type of antibiotic that uses an unusual virus to defeat ...

Some of the most common symptoms are: Fever Sore throat Body rash Tiredness Muscle and Joint pain It indicates that the body’s immune system is fighting against the virus. However, having ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this ...

PD-1 inhibitors re-activate the T cells, thereby fortifying the patient’s immune system to fight cancer more effectively. However, these therapies don’t work for everyone, and scientists must ...

As a general rule, most people want to avoid viruses, which are at the root of ... There are countless cures and solutions for fighting zits, bumps and clogged pores, from diet restrictions ...

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors. Researchers at the Johns ...

PD-1 inhibitors turn the patient’s T cells back on, allowing patients’ immune systems to fight cancer more effectively. But not all patients respond to these therapies, and scientists need to ...